A Phase 2b clinical trial involving insulin lispro has been marked completed as of July 31, 2026. The study, registered as NCT06238778, is titled "Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec." It was designed to compare HDV-insulin lispro against standard insulin lispro in adult participants with type 1 diabetes who were also receiving insulin degludec. The trial's phase is listed as Phase 2. Its current status on record is completed. No results or outcome data are included in this update. This report reflects only the change in trial status and the details provided in the registry entry. No efficacy, safety, or comparative performance information has been disclosed as part of this status update. Readers interested in the trial details can consult the official registry listing for further documentation as it becomes available. For general background on insulin lispro, including its approved uses and regulatory status, readers can refer to the compound overview.
Phase 2b Trial of HDV-Insulin Lispro vs Insulin Lispro Marked Completed
See the full insulin lispro overview
Source: https://clinicaltrials.gov/study/NCT06238778